The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Broccoli Sprout Extract in Preventing Lung Cancer in Smokers
- Conditions
- Lung Cancer
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2010-08-09
- Target Recruit Count
- 70
- Registration Number
- NCT00255775
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
- Conditions
- Brain and Central Nervous System TumorsThromboembolism
- First Posted Date
- 2005-11-15
- Last Posted Date
- 2018-06-28
- Target Recruit Count
- 110
- Registration Number
- NCT00253669
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Study of PET Scans and Serotonin in Hot Flashes Treatment
- Conditions
- Hot Flashes
- Interventions
- Drug: Conjugated equine estrogen
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2014-10-02
- Target Recruit Count
- 5
- Registration Number
- NCT00249847
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2005-11-04
- Last Posted Date
- 2018-09-04
- Target Recruit Count
- 16
- Registration Number
- NCT00248534
- Locations
- 🇺🇸
M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
🇺🇸University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
🇺🇸Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2018-08-23
- Target Recruit Count
- 7
- Registration Number
- NCT00245115
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2013-03-19
- Target Recruit Count
- 54
- Registration Number
- NCT00244959
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma
- Conditions
- Sarcoma
- Interventions
- Biological: filgrastimProcedure: peripheral blood stem cell transplantationRadiation: Sm-EDTMP (low dose)Radiation: sm-EDTMP (higher dose)
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2020-03-10
- Target Recruit Count
- 11
- Registration Number
- NCT00245011
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2005-10-21
- Last Posted Date
- 2017-09-28
- Target Recruit Count
- 44
- Registration Number
- NCT00242996
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2005-10-13
- Last Posted Date
- 2018-06-27
- Target Recruit Count
- 15
- Registration Number
- NCT00238277
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
- Conditions
- Lymphoma
- First Posted Date
- 2005-10-13
- Last Posted Date
- 2017-11-06
- Target Recruit Count
- 59
- Registration Number
- NCT00238368
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States